The Centers for Disease Control and Prevention (CDC) awarded a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract titled "Test Surge and Data Sharing" to Quest Diagnostics Incorporated, a provider of diagnostic information services. The $118 million IDIQ contract has a period of performance through September 2029 and allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an as-needed basis. The contract does not have a set-aside designation.
Under this IDIQ, the CDC has issued several delivery orders to Quest Diagnostics, including a $3.6 million firm fixed-price contract for clinical laboratory testing and analysis to support the CDC's population health, precision medicine, and health plan operations initiatives; a $6.6 million firm fixed-price contract for test surge and data sharing services; a $493,118 time and materials contract for test surge and data sharing; and a $325,072 time and materials contract for the development of H5N1 testing capabilities. Quest Diagnostics has previously provided similar diagnostic services to other federal agencies such as the Department of Justice and Department of Veterans Affairs.
Generated 12/6/24, 9:06 AM